US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

43.96

+0.68001.57%

Post-market: 43.960.00000.00%16:10 EST

Volume:485.25K

Turnover:21.17M

Market Cap:3.33B

PE:94.17

High:44.16

Open:43.34

Low:43.15

Close:43.28

52wk High:45.00

52wk Low:18.12

Shares:75.80M

Float Shares:35.24M

Volume Ratio:0.74

T/O Rate:1.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.4668

EPS(LYR):-0.6047

ROE:7.39%

ROA:3.76%

PB:6.22

PE(LYR):-72.69

Loading ...

Overview Company News Filings

Kiniksa Pharmaceuticals Appoints Ross Moat COO and Eben Tessari Chief Strategy Officer

Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush

Wedbush Adjusts Price Target on Kiniksa Pharmaceuticals International to $50 From $48, Maintains Outperform Rating

MT Newswires Live

Kiniksa Pharmaceuticals Showcases Pipeline Progress and Cardiovascular Focus in New Corporate Presentation

Kiniksa Projects Continued Annual Cash Flow Positivity for 2026

Kiniksa Pharmaceuticals International Plc - Kpl-387 Phase 2 Data Expected in 2H 2026

THOMSON REUTERS

Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares

How Investors Are Reacting To Kiniksa (KNSA) KPL-387 Progress And A Fresh Analyst Buy Rating

Simply Wall St.

Director Barry D. Quart Reports Disposal of Kiniksa Pharmaceuticals International plc Common Shares

US High Growth Tech Stocks to Watch

Simply Wall St.

Kiniksa COO Eben Tessari Reports Disposal of Common Shares

Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.

Kiniksa CFO Mark Ragosa Reports Sale of Common Shares

Kiniksa Pharmaceuticals International Plc : Jefferies Raises Target Price to $58 From $54

THOMSON REUTERS

Stock Track | Kiniksa Pharmaceuticals Plummets 11.98% as Q3 Earnings Fall Short of Expectations

Kiniksa Pharmaceuticals International PLC reports results for the quarter ended September 30 - Earnings Summary

Kiniksa Pharmaceuticals Showcases Growth in Recurrent Pericarditis Market and Advances Cardiovascular Drug Pipeline

Stock Track | Kiniksa Pharmaceuticals Plunges 6.53% Pre-Market on Q3 Earnings Miss

Kiniksa Pharma raises ARCALYST's 2025 sales forecast

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KNSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KNSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KNSA\",,,,,undefined,":{"symbol":"KNSA","market":"US","secType":"STK","nameCN":"Kiniksa Pharmaceuticals Ltd.","latestPrice":43.96,"timestamp":1769720400000,"preClose":43.28,"halted":0,"volume":485246,"hourTrading":{"tag":"盘后","latestPrice":43.96,"preClose":43.96,"latestTime":"16:10 EST","volume":8872,"amount":390013.12,"timestamp":1769721004933,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01571164510166358,"floatShares":35244400,"shares":75795759,"eps":0.466834,"marketStatus":"Post-Mkt","change":0.68,"latestTime":"01-29 17:15:55 EST","open":43.34,"high":44.155,"low":43.145,"amount":21171496.16574,"amplitude":0.023336,"askPrice":45.68,"askSize":5,"bidPrice":41.33,"bidSize":6,"shortable":3,"etf":0,"ttmEps":0.466834,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1769734800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1527134400000,"exchange":"NASDAQ","adjPreClose":43.28,"preHourTrading":{"tag":"盘前","latestPrice":43.3,"preClose":43.28,"latestTime":"09:25 EST","volume":22,"amount":952.5999999999999,"timestamp":1769696700003,"change":0.02,"changeRate":0.000462,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":43.96,"preClose":43.96,"latestTime":"16:10 EST","volume":8872,"amount":390013.12,"timestamp":1769721004933,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.736872,"impliedVol":0.2858,"impliedVolPercentile":0.1793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KNSA\",,,,,undefined,":{"symbol":"KNSA","floatShares":35244400,"roa":"3.76%","roe":"7.39%","lyrEps":-0.604739,"volumeRatio":0.736872,"shares":75795759,"dividePrice":0,"high":44.155,"amplitude":0.023336,"preClose":43.28,"low":43.145,"week52Low":18.12,"pbRate":"6.22","psRate":"5.57","week52High":45,"institutionHeld":0,"latestPrice":43.96,"committee":0.090909,"eps":0.466834,"divideRate":0,"volume":485246,"delay":0,"ttmEps":0.466834,"open":43.34,"prevYearClose":41.25,"prevWeekClose":42.2,"prevMonthClose":41.25,"prevQuarterClose":41.25,"fiveDayClose":42.44,"twentyDayClose":40.99,"sixtyDayClose":37.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KNSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-28","symbol":"KNSA","fiscalQuarterEnding":"2025/09","expectedEps":0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.23},{"market":"US","date":"2025-07-29","symbol":"KNSA","fiscalQuarterEnding":"2025/06","expectedEps":0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"pre","actualEps":0.23},{"market":"US","date":"2024-10-29","symbol":"KNSA","fiscalQuarterEnding":"2024/09","expectedEps":-0.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-07-23","symbol":"KNSA","fiscalQuarterEnding":"2024/06","expectedEps":-0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1721707200000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2024-04-23","symbol":"KNSA","fiscalQuarterEnding":"2024/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1713844800000,"reportTimeType":"pre","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KNSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KNSA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1759122000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KNSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KNSA","date":"2026-01-28","current":92.709614,"percent":0.886808,"low":-219.570863,"twenty":-120.275096,"median":-4.638475,"eighty":7.452148,"high":603.227135,"avg":2.460343,"sd":153.997029,"marketCap":3383522681},"quantilePoints":[{"date":"2021-01-29","current":-9.607138,"twenty":-10.736035,"median":-8.577974,"eighty":-4.745893,"marketCap":1340397439},{"date":"2021-02-05","current":-10.446359,"twenty":-10.733257,"median":-8.604301,"eighty":-4.745996,"marketCap":1457486499},{"date":"2021-02-12","current":-9.973077,"twenty":-10.736035,"median":-8.617927,"eighty":-4.746148,"marketCap":1391453715},{"date":"2021-02-19","current":-11.695434,"twenty":-10.793321,"median":-8.621611,"eighty":-4.75103,"marketCap":1631758588},{"date":"2021-02-26","current":-8.697049,"twenty":-10.793321,"median":-8.625871,"eighty":-4.75988,"marketCap":1403538493},{"date":"2021-03-05","current":-9.458094,"twenty":-10.76016,"median":-8.642297,"eighty":-4.763572,"marketCap":1526356640},{"date":"2021-03-12","current":-9.817476,"twenty":-10.739214,"median":-8.658776,"eighty":-4.764018,"marketCap":1584354098},{"date":"2021-03-19","current":-8.515244,"twenty":-10.733813,"median":-8.662526,"eighty":-4.764018,"marketCap":1374198602},{"date":"2021-03-26","current":-7.056575,"twenty":-10.732256,"median":-8.652976,"eighty":-4.769736,"marketCap":1138797153},{"date":"2021-04-01","current":-7.813392,"twenty":-10.721705,"median":-8.636177,"eighty":-4.77126,"marketCap":1260932977},{"date":"2021-04-09","current":-7.479378,"twenty":-10.699906,"median":-8.624,"eighty":-4.773373,"marketCap":1207029457},{"date":"2021-04-16","current":-6.608404,"twenty":-10.687492,"median":-8.62154,"eighty":-4.799391,"marketCap":1066470911},{"date":"2021-04-23","current":-6.946646,"twenty":-10.673895,"median":-8.614276,"eighty":-4.816906,"marketCap":1121056754},{"date":"2021-04-30","current":-6.969502,"twenty":-10.66515,"median":-8.598771,"eighty":-4.830492,"marketCap":1124745279},{"date":"2021-05-07","current":-5.420002,"twenty":-10.656626,"median":-8.569496,"eighty":-4.846103,"marketCap":999697657},{"date":"2021-05-14","current":-5.234766,"twenty":-10.630794,"median":-8.55811,"eighty":-4.85448,"marketCap":965531640},{"date":"2021-05-21","current":-5.179195,"twenty":-10.612166,"median":-8.546515,"eighty":-4.858972,"marketCap":955281835},{"date":"2021-05-28","current":-5.04953,"twenty":-10.587909,"median":-8.526884,"eighty":-4.866872,"marketCap":931365623},{"date":"2021-06-04","current":-4.942093,"twenty":-10.573525,"median":-8.515936,"eighty":-4.878383,"marketCap":911549333},{"date":"2021-06-11","current":-5.50521,"twenty":-10.570994,"median":-8.506716,"eighty":-4.892517,"marketCap":1015414025},{"date":"2021-06-18","current":-5.564486,"twenty":-10.567472,"median":-8.486734,"eighty":-4.898513,"marketCap":1026347150},{"date":"2021-06-25","current":-5.568191,"twenty":-10.55134,"median":-8.461177,"eighty":-4.901914,"marketCap":1027030471},{"date":"2021-07-02","current":-5.216242,"twenty":-10.523061,"median":-8.423324,"eighty":-4.907247,"marketCap":962115038},{"date":"2021-07-09","current":-5.37925,"twenty":-10.514318,"median":-8.410759,"eighty":-4.910548,"marketCap":992181133},{"date":"2021-07-16","current":-5.012483,"twenty":-10.499608,"median":-8.399251,"eighty":-4.910676,"marketCap":924532420},{"date":"2021-07-23","current":-5.371841,"twenty":-10.439395,"median":-8.355604,"eighty":-4.911776,"marketCap":990814493},{"date":"2021-07-30","current":-5.679332,"twenty":-10.408057,"median":-8.333668,"eighty":-4.915271,"marketCap":1047530081},{"date":"2021-08-06","current":-4.771973,"twenty":-10.390073,"median":-8.309271,"eighty":-4.910676,"marketCap":899707869},{"date":"2021-08-13","current":-4.448511,"twenty":-10.37168,"median":-8.253789,"eighty":-4.90087,"marketCap":838722340},{"date":"2021-08-20","current":-4.433974,"twenty":-10.363038,"median":-8.151634,"eighty":-4.862509,"marketCap":835981417},{"date":"2021-08-27","current":-4.648404,"twenty":-10.360551,"median":-8.136613,"eighty":-4.821915,"marketCap":876410026},{"date":"2021-09-03","current":-4.477587,"twenty":-10.34743,"median":-8.102593,"eighty":-4.771453,"marketCap":844204185},{"date":"2021-09-10","current":-4.506662,"twenty":-10.330332,"median":-8.090185,"eighty":-4.764018,"marketCap":849686030},{"date":"2021-09-17","current":-4.430339,"twenty":-10.329259,"median":-8.075215,"eighty":-4.75225,"marketCap":835296186},{"date":"2021-09-24","current":-4.223178,"twenty":-10.324026,"median":-8.064534,"eighty":-4.717557,"marketCap":796238038},{"date":"2021-10-01","current":-4.172297,"twenty":-10.324026,"median":-8.036911,"eighty":-4.692017,"marketCap":786644809},{"date":"2021-10-08","current":-4.066899,"twenty":-10.301331,"median":-7.959751,"eighty":-4.660374,"marketCap":766773119},{"date":"2021-10-15","current":-4.161393,"twenty":-10.27233,"median":-7.91445,"eighty":-4.648404,"marketCap":784589117},{"date":"2021-10-22","current":-3.896082,"twenty":-10.266529,"median":-7.911102,"eighty":-4.584708,"marketCap":734567278},{"date":"2021-10-29","current":-3.776147,"twenty":-10.260729,"median":-7.815469,"eighty":-4.561178,"marketCap":711954666},{"date":"2021-11-05","current":-5.790232,"twenty":-10.260729,"median":-7.810062,"eighty":-4.561178,"marketCap":1014726647},{"date":"2021-11-12","current":-5.26349,"twenty":-10.259113,"median":-7.763062,"eighty":-4.572081,"marketCap":922416144},{"date":"2021-11-19","current":-4.795712,"twenty":-10.257698,"median":-7.72399,"eighty":-4.572081,"marketCap":840438907},{"date":"2021-11-26","current":-4.579512,"twenty":-10.250842,"median":-7.665411,"eighty":-4.572081,"marketCap":802550267},{"date":"2021-12-03","current":-4.65813,"twenty":-10.244398,"median":-7.642221,"eighty":-4.566411,"marketCap":816327954},{"date":"2021-12-10","current":-5.145563,"twenty":-10.234025,"median":-7.58715,"eighty":-4.571209,"marketCap":901749614},{"date":"2021-12-17","current":-5.353901,"twenty":-10.231727,"median":-7.563346,"eighty":-4.572081,"marketCap":938260484},{"date":"2021-12-23","current":-5.165217,"twenty":-10.224834,"median":-7.460076,"eighty":-4.57654,"marketCap":905194035},{"date":"2021-12-31","current":-4.626683,"twenty":-10.220171,"median":-7.396307,"eighty":-4.58263,"marketCap":810816879},{"date":"2022-01-07","current":-4.308279,"twenty":-10.206563,"median":-7.34319,"eighty":-4.572081,"marketCap":755017247},{"date":"2022-01-14","current":-4.453723,"twenty":-10.193813,"median":-7.279761,"eighty":-4.561178,"marketCap":780505968},{"date":"2022-01-21","current":-4.076355,"twenty":-10.191255,"median":-7.253194,"eighty":-4.528429,"marketCap":714373070},{"date":"2022-01-28","current":-4.363312,"twenty":-10.188805,"median":-7.213857,"eighty":-4.504481,"marketCap":764661628},{"date":"2022-02-04","current":-4.048839,"twenty":-10.183486,"median":-7.158048,"eighty":-4.486553,"marketCap":709550880},{"date":"2022-02-11","current":-4.210006,"twenty":-10.180549,"median":-7.100969,"eighty":-4.454546,"marketCap":737795138},{"date":"2022-02-18","current":-4.213937,"twenty":-10.172983,"median":-7.052347,"eighty":-4.450485,"marketCap":738484023},{"date":"2022-02-25","current":-4.533331,"twenty":-10.159374,"median":-7.029209,"eighty":-4.449498,"marketCap":715921780},{"date":"2022-03-04","current":-4.187643,"twenty":-10.143979,"median":-6.996545,"eighty":-4.446391,"marketCap":661329289},{"date":"2022-03-11","current":-4.218273,"twenty":-10.121829,"median":-6.980471,"eighty":-4.431066,"marketCap":666166599},{"date":"2022-03-18","current":-4.804631,"twenty":-10.109184,"median":-6.94876,"eighty":-4.427033,"marketCap":758766520},{"date":"2022-03-25","current":-4.244528,"twenty":-10.101262,"median":-6.871975,"eighty":-4.416772,"marketCap":670312864},{"date":"2022-04-01","current":-4.703987,"twenty":-10.069934,"median":-6.842367,"eighty":-4.410594,"marketCap":742872504},{"date":"2022-04-08","current":-4.99279,"twenty":-10.06858,"median":-6.807122,"eighty":-4.412616,"marketCap":788481420},{"date":"2022-04-14","current":-4.914026,"twenty":-10.064156,"median":-6.743227,"eighty":-4.414413,"marketCap":776042625},{"date":"2022-04-22","current":-4.410809,"twenty":-10.063482,"median":-6.658663,"eighty":-4.414413,"marketCap":696572543},{"date":"2022-04-29","current":-4.092619,"twenty":-10.050455,"median":-6.574219,"eighty":-4.410201,"marketCap":646322697},{"date":"2022-05-06","current":-4.545814,"twenty":-10.040318,"median":-6.543665,"eighty":-4.410201,"marketCap":607548099},{"date":"2022-05-13","current":-4.260729,"twenty":-10.021869,"median":-6.404693,"eighty":-4.384554,"marketCap":569446451},{"date":"2022-05-20","current":-4.478431,"twenty":-9.993251,"median":-6.283153,"eighty":-4.375823,"marketCap":598542255},{"date":"2022-05-27","current":-4.182979,"twenty":-9.973077,"median":-6.163275,"eighty":-4.363312,"marketCap":559055092},{"date":"2022-06-03","current":-4.146695,"twenty":-9.952626,"median":-6.104937,"eighty":-4.355145,"marketCap":554205792},{"date":"2022-06-10","current":-4.333296,"twenty":-9.930232,"median":-6.055178,"eighty":-4.353923,"marketCap":579145052},{"date":"2022-06-17","current":-4.727232,"twenty":-9.92391,"median":-5.997831,"eighty":-4.348672,"marketCap":631794602},{"date":"2022-06-24","current":-5.33887,"twenty":-9.918275,"median":-5.960807,"eighty":-4.352173,"marketCap":713539957},{"date":"2022-07-01","current":-5.245569,"twenty":-9.913568,"median":-5.906312,"eighty":-4.353923,"marketCap":701070326},{"date":"2022-07-08","current":-5.737989,"twenty":-9.906932,"median":-5.886932,"eighty":-4.354534,"marketCap":766882264},{"date":"2022-07-15","current":-5.83129,"twenty":-9.885252,"median":-5.871583,"eighty":-4.355907,"marketCap":779351895},{"date":"2022-07-22","current":-5.691339,"twenty":-9.85854,"median":-5.871756,"eighty":-4.357061,"marketCap":760647449},{"date":"2022-07-29","current":-5.136718,"twenty":-9.846961,"median":-5.857207,"eighty":-4.359983,"marketCap":686522424},{"date":"2022-08-05","current":-8.312876,"twenty":-9.844655,"median":-5.859248,"eighty":-4.364884,"marketCap":931607437},{"date":"2022-08-12","current":-7.692975,"twenty":-9.840702,"median":-5.871929,"eighty":-4.368916,"marketCap":862136338},{"date":"2022-08-19","current":-7.22185,"twenty":-9.829375,"median":-5.89275,"eighty":-4.373185,"marketCap":809338303},{"date":"2022-08-26","current":-7.575194,"twenty":-9.816958,"median":-5.923745,"eighty":-4.378899,"marketCap":848936829},{"date":"2022-09-02","current":-7.091671,"twenty":-9.807758,"median":-5.963672,"eighty":-4.38393,"marketCap":794749372},{"date":"2022-09-09","current":-6.769322,"twenty":-9.793634,"median":-6.002677,"eighty":-4.384669,"marketCap":758624401},{"date":"2022-09-16","current":-6.527561,"twenty":-9.784376,"median":-6.043167,"eighty":-4.385483,"marketCap":731530672},{"date":"2022-09-23","current":-6.775521,"twenty":-9.771181,"median":-6.080438,"eighty":-4.388469,"marketCap":759319112},{"date":"2022-09-30","current":-7.959533,"twenty":-9.769244,"median":-6.146117,"eighty":-4.395333,"marketCap":892008911},{"date":"2022-10-07","current":-8.610429,"twenty":-9.76042,"median":-6.21991,"eighty":-4.400144,"marketCap":964953565},{"date":"2022-10-14","current":-8.412061,"twenty":-9.749558,"median":-6.372607,"eighty":-4.410323,"marketCap":942722813},{"date":"2022-10-21","current":-7.754965,"twenty":-9.724407,"median":-6.505268,"eighty":-4.411081,"marketCap":869083448},{"date":"2022-10-28","current":-7.265243,"twenty":-9.699464,"median":-6.53376,"eighty":-4.412616,"marketCap":814201280},{"date":"2022-11-04","current":6.776675,"twenty":-9.68624,"median":-6.523865,"eighty":-4.400144,"marketCap":966143832},{"date":"2022-11-11","current":7.505796,"twenty":-9.6846,"median":-6.404693,"eighty":-4.384669,"marketCap":1070093817},{"date":"2022-11-18","current":7.856944,"twenty":-9.681333,"median":-6.283153,"eighty":-4.368079,"marketCap":1120156685},{"date":"2022-11-25","current":7.686247,"twenty":-9.677951,"median":-6.172097,"eighty":-4.356592,"marketCap":1095820569},{"date":"2022-12-02","current":8.13006,"twenty":-9.676209,"median":-6.104937,"eighty":-4.349547,"marketCap":1159094472},{"date":"2022-12-09","current":7.608214,"twenty":-9.661039,"median":-6.055498,"eighty":-4.340796,"marketCap":1084695487},{"date":"2022-12-16","current":7.739895,"twenty":-9.660484,"median":-6.012757,"eighty":-4.327668,"marketCap":1103469062},{"date":"2022-12-23","current":7.539935,"twenty":-9.656811,"median":-5.982184,"eighty":-4.308279,"marketCap":1074961040},{"date":"2022-12-30","current":7.305836,"twenty":-9.648299,"median":-5.950474,"eighty":-4.296908,"marketCap":1041585794},{"date":"2023-01-06","current":7.700878,"twenty":-9.646171,"median":-5.919712,"eighty":-4.292662,"marketCap":1097906521},{"date":"2023-01-13","current":7.096123,"twenty":-9.631534,"median":-5.888554,"eighty":-4.284855,"marketCap":1011687137},{"date":"2023-01-20","current":6.85227,"twenty":-9.621776,"median":-5.871929,"eighty":-4.276741,"marketCap":976921256},{"date":"2023-01-27","current":6.823007,"twenty":-9.620233,"median":-5.859248,"eighty":-4.24487,"marketCap":972749350},{"date":"2023-02-03","current":6.876655,"twenty":-9.613607,"median":-5.845265,"eighty":-4.240058,"marketCap":980397844},{"date":"2023-02-10","current":6.774237,"twenty":-9.60233,"median":-5.830846,"eighty":-4.228182,"marketCap":965796174},{"date":"2023-02-17","current":6.930303,"twenty":-9.594722,"median":-5.804421,"eighty":-4.220107,"marketCap":988046338},{"date":"2023-02-24","current":6.306039,"twenty":-9.593021,"median":-5.795006,"eighty":-4.217423,"marketCap":899045682},{"date":"2023-03-03","current":4.671435,"twenty":-9.586385,"median":-5.771417,"eighty":-4.210792,"marketCap":856568350},{"date":"2023-03-10","current":4.561116,"twenty":-9.575651,"median":-5.737989,"eighty":-4.188783,"marketCap":836339944},{"date":"2023-03-17","current":4.340478,"twenty":-9.567191,"median":-5.717005,"eighty":-4.173397,"marketCap":795883133},{"date":"2023-03-24","current":4.340478,"twenty":-9.563475,"median":-5.691339,"eighty":-4.163528,"marketCap":795883133},{"date":"2023-03-31","current":4.093212,"twenty":-9.56277,"median":-5.681742,"eighty":-4.142549,"marketCap":750543603},{"date":"2023-04-06","current":3.971481,"twenty":-9.560948,"median":-5.677348,"eighty":-4.139587,"marketCap":728222604},{"date":"2023-04-14","current":4.424169,"twenty":-9.558346,"median":-5.661377,"eighty":-4.119677,"marketCap":811228820},{"date":"2023-04-21","current":4.355695,"twenty":-9.553947,"median":-5.642748,"eighty":-4.094861,"marketCap":798673258},{"date":"2023-04-28","current":4.101761,"twenty":-9.553466,"median":-5.611034,"eighty":-4.066899,"marketCap":752111206},{"date":"2023-05-05","current":4.828392,"twenty":-9.548587,"median":-5.582529,"eighty":-4.05281,"marketCap":947827877},{"date":"2023-05-12","current":4.953068,"twenty":-9.548587,"median":-5.568147,"eighty":-4.017071,"marketCap":972302184},{"date":"2023-05-19","current":4.703813,"twenty":-9.535236,"median":-5.537691,"eighty":-3.986942,"marketCap":923372527},{"date":"2023-05-26","current":4.903217,"twenty":-9.512111,"median":-5.531143,"eighty":-3.976039,"marketCap":962516252},{"date":"2023-06-02","current":5.042088,"twenty":-9.495527,"median":-5.508796,"eighty":-3.962645,"marketCap":989777061},{"date":"2023-06-09","current":5.351878,"twenty":-9.461113,"median":-5.471868,"eighty":-3.916434,"marketCap":1050589635},{"date":"2023-06-16","current":5.825464,"twenty":-9.400374,"median":-5.450208,"eighty":-3.896731,"marketCap":1143555983},{"date":"2023-06-23","current":5.679471,"twenty":-9.335742,"median":-5.414445,"eighty":-3.850677,"marketCap":1114897184},{"date":"2023-06-30","current":5.109743,"twenty":-9.273337,"median":-5.400173,"eighty":-3.635233,"marketCap":1003057968},{"date":"2023-07-07","current":4.928143,"twenty":-9.259017,"median":-5.393025,"eighty":-3.522416,"marketCap":967409218},{"date":"2023-07-14","current":4.953068,"twenty":-9.233761,"median":-5.378467,"eighty":-3.399167,"marketCap":972302184},{"date":"2023-07-21","current":5.40885,"twenty":-9.20676,"median":-5.359603,"eighty":-3.345068,"marketCap":1061773556},{"date":"2023-07-28","current":5.594838,"twenty":-9.182562,"median":-5.333686,"eighty":-3.200406,"marketCap":1293839930},{"date":"2023-08-04","current":5.704231,"twenty":-9.179657,"median":-5.305156,"eighty":-3.077875,"marketCap":1319137682},{"date":"2023-08-11","current":5.279448,"twenty":-9.179657,"median":-5.26349,"eighty":-2.990102,"marketCap":1220904025},{"date":"2023-08-18","current":4.969963,"twenty":-9.147965,"median":-5.245569,"eighty":-2.96235,"marketCap":1149333789},{"date":"2023-08-25","current":5.355302,"twenty":-9.130654,"median":-5.238471,"eighty":-2.851988,"marketCap":1238445749},{"date":"2023-09-01","current":5.227867,"twenty":-9.068953,"median":-5.223652,"eighty":-2.818855,"marketCap":1208975652},{"date":"2023-09-08","current":5.182355,"twenty":-9.001907,"median":-5.214184,"eighty":-2.64998,"marketCap":1198450617},{"date":"2023-09-15","current":5.23697,"twenty":-8.95144,"median":-5.180941,"eighty":-2.420221,"marketCap":1211080659},{"date":"2023-09-22","current":5.20056,"twenty":-8.910587,"median":-5.165217,"eighty":-2.321768,"marketCap":1202660631},{"date":"2023-09-29","current":5.285516,"twenty":-8.847285,"median":-5.159132,"eighty":-2.22812,"marketCap":1222307363},{"date":"2023-10-06","current":4.960861,"twenty":-8.819961,"median":-5.134424,"eighty":-2.155201,"marketCap":1147228782},{"date":"2023-10-13","current":4.830391,"twenty":-8.760922,"median":-5.121977,"eighty":-2.098965,"marketCap":1117057016},{"date":"2023-10-20","current":4.80005,"twenty":-8.720862,"median":-5.094461,"eighty":-1.969031,"marketCap":1110040326},{"date":"2023-10-27","current":4.596761,"twenty":-8.695972,"median":-5.078696,"eighty":-1.922624,"marketCap":1063028504},{"date":"2023-11-03","current":-167.647452,"twenty":-8.69078,"median":-5.070731,"eighty":-1.914879,"marketCap":1121896746},{"date":"2023-11-10","current":-151.040368,"twenty":-8.69078,"median":-5.070731,"eighty":-1.914879,"marketCap":1010762146},{"date":"2023-11-17","current":-162.917586,"twenty":-8.695972,"median":-5.070731,"eighty":-1.914879,"marketCap":1090244487},{"date":"2023-11-24","current":-167.857668,"twenty":-8.706003,"median":-5.070731,"eighty":-1.914879,"marketCap":1123303513},{"date":"2023-12-01","current":-169.95983,"twenty":-8.706003,"median":-5.070731,"eighty":-1.914879,"marketCap":1137371184},{"date":"2023-12-08","current":-187.092454,"twenty":-8.7089,"median":-5.074518,"eighty":-1.91617,"marketCap":1252022701},{"date":"2023-12-15","current":-179.209345,"twenty":-8.7089,"median":-5.074518,"eighty":-1.91617,"marketCap":1199268935},{"date":"2023-12-22","current":-189.299724,"twenty":-8.7089,"median":-5.074518,"eighty":-1.91617,"marketCap":1266793755},{"date":"2023-12-29","current":-187.617994,"twenty":-8.706003,"median":-5.070731,"eighty":-1.914879,"marketCap":1255539618},{"date":"2024-01-05","current":-201.01928,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1345221020},{"date":"2024-01-12","current":-202.648456,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1356123465},{"date":"2024-01-19","current":-197.182833,"twenty":-8.697082,"median":-5.065585,"eighty":-1.912943,"marketCap":1319547521},{"date":"2024-01-26","current":-192.8734,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1290708795},{"date":"2024-02-02","current":-191.401887,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1280861426},{"date":"2024-02-09","current":-199.915645,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1337835493},{"date":"2024-02-16","current":-212.003078,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1418724600},{"date":"2024-02-23","current":-207.273213,"twenty":-8.697215,"median":-5.066945,"eighty":-1.913588,"marketCap":1387072340},{"date":"2024-03-01","current":105.992727,"twenty":-8.695972,"median":-5.06362,"eighty":-1.900035,"marketCap":1492801565},{"date":"2024-03-08","current":106.594388,"twenty":-8.671026,"median":-5.024993,"eighty":2.789587,"marketCap":1501275367},{"date":"2024-03-15","current":102.031788,"twenty":-8.64597,"median":-4.999896,"eighty":4.07343,"marketCap":1437015697},{"date":"2024-03-22","current":99.274172,"twenty":-8.620909,"median":-4.971369,"eighty":4.100999,"marketCap":1398177435},{"date":"2024-03-28","current":100.226803,"twenty":-8.604287,"median":-4.957009,"eighty":4.203531,"marketCap":1411594289},{"date":"2024-04-05","current":90.550078,"twenty":-8.56363,"median":-4.927274,"eighty":4.272005,"marketCap":1275307297},{"date":"2024-04-12","current":88.745093,"twenty":-8.526884,"median":-4.911189,"eighty":4.340478,"marketCap":1249885889},{"date":"2024-04-19","current":84.633738,"twenty":-8.514198,"median":-4.905046,"eighty":4.389932,"marketCap":1191981571},{"date":"2024-04-26","current":144.422654,"twenty":-8.486712,"median":-4.870817,"eighty":4.481123,"marketCap":1249255953},{"date":"2024-05-03","current":158.938729,"twenty":-8.473798,"median":-4.85714,"eighty":4.589632,"marketCap":1374820010},{"date":"2024-05-10","current":165.581679,"twenty":-8.473798,"median":-4.828348,"eighty":4.691185,"marketCap":1432281527},{"date":"2024-05-17","current":164.925586,"twenty":-8.473798,"median":-4.802137,"eighty":4.758131,"marketCap":1426606315},{"date":"2024-05-24","current":157.216483,"twenty":-8.473798,"median":-4.771648,"eighty":4.82843,"marketCap":1359922579},{"date":"2024-05-31","current":152.295779,"twenty":-8.473798,"median":-4.76645,"eighty":4.857535,"marketCap":1317358492},{"date":"2024-06-07","current":160.086894,"twenty":-8.473798,"median":-4.761061,"eighty":4.873307,"marketCap":1384751630},{"date":"2024-06-14","current":153.854002,"twenty":-8.474351,"median":-4.747745,"eighty":4.903217,"marketCap":1330837120},{"date":"2024-06-21","current":147.457088,"twenty":-8.477441,"median":-4.730925,"eighty":4.946502,"marketCap":1275503807},{"date":"2024-06-28","current":152.459803,"twenty":-8.486712,"median":-4.706554,"eighty":4.953068,"marketCap":1318777295},{"date":"2024-07-05","current":156.956244,"twenty":-8.486712,"median":-4.693508,"eighty":4.968143,"marketCap":1357671509},{"date":"2024-07-12","current":177.500255,"twenty":-8.486712,"median":-4.660374,"eighty":4.98513,"marketCap":1535377204},{"date":"2024-07-15","current":174.295389,"twenty":-8.486712,"median":-4.65813,"eighty":4.999363,"marketCap":1507655116},{"date":"2024-08-02","current":-179.467298,"twenty":-8.518729,"median":-4.657452,"eighty":5.024064,"marketCap":1835950458},{"date":"2024-08-09","current":-172.503103,"twenty":-8.55386,"median":-4.692762,"eighty":5.024064,"marketCap":1764706746},{"date":"2024-08-16","current":-182.252976,"twenty":-8.600955,"median":-4.709858,"eighty":5.024064,"marketCap":1864447943},{"date":"2024-08-23","current":-182.531544,"twenty":-8.621775,"median":-4.745945,"eighty":5.024064,"marketCap":1867297691},{"date":"2024-08-30","current":-186.361851,"twenty":-8.66194,"median":-4.761061,"eighty":5.024064,"marketCap":1906481733},{"date":"2024-09-06","current":-176.68162,"twenty":-8.693817,"median":-4.769759,"eighty":5.024064,"marketCap":1807452973},{"date":"2024-09-13","current":-170.553129,"twenty":-8.731485,"median":-4.802137,"eighty":5.024064,"marketCap":1744758506},{"date":"2024-09-20","current":-182.810111,"twenty":-8.789852,"median":-4.847403,"eighty":5.024064,"marketCap":1870147440},{"date":"2024-09-27","current":-166.862105,"twenty":-8.844146,"median":-4.864214,"eighty":5.024064,"marketCap":1706999339},{"date":"2024-10-04","current":-169.16029,"twenty":-8.906485,"median":-4.908077,"eighty":5.024064,"marketCap":1730509764},{"date":"2024-10-11","current":-177.517323,"twenty":-8.951085,"median":-4.929126,"eighty":5.024064,"marketCap":1816002218},{"date":"2024-10-18","current":-186.292209,"twenty":-9.042824,"median":-4.964984,"eighty":5.024064,"marketCap":1905769296},{"date":"2024-10-25","current":-187.476122,"twenty":-9.126049,"median":-5.01063,"eighty":5.024064,"marketCap":1917880727},{"date":"2024-10-31","current":-183.211073,"twenty":-9.135796,"median":-5.0314,"eighty":5.024064,"marketCap":1661358010},{"date":"2024-11-08","current":-183.211073,"twenty":-9.181852,"median":-5.074518,"eighty":5.025325,"marketCap":1661358010},{"date":"2024-11-15","current":-173.656389,"twenty":-9.220318,"median":-5.098736,"eighty":5.025325,"marketCap":1574716132},{"date":"2024-11-22","current":-167.923578,"twenty":-9.26657,"median":-5.123624,"eighty":5.025325,"marketCap":1522731005},{"date":"2024-11-29","current":-175.806193,"twenty":-9.327593,"median":-5.145563,"eighty":5.025325,"marketCap":1594210555},{"date":"2024-12-06","current":-167.047732,"twenty":-9.462622,"median":-5.165217,"eighty":5.025325,"marketCap":1514788833},{"date":"2024-12-13","current":-160.359453,"twenty":-9.520874,"median":-5.180941,"eighty":5.025325,"marketCap":1454139519},{"date":"2024-12-20","current":-163.146236,"twenty":-9.553755,"median":-5.223652,"eighty":5.025325,"marketCap":1479410066},{"date":"2024-12-27","current":-160.120586,"twenty":-9.566152,"median":-5.234766,"eighty":5.025325,"marketCap":1451973472},{"date":"2025-01-03","current":-158.767006,"twenty":-9.601934,"median":-5.242175,"eighty":5.025325,"marketCap":1439699206},{"date":"2025-01-10","current":-161.633411,"twenty":-9.646171,"median":-5.258277,"eighty":5.026585,"marketCap":1465691769},{"date":"2025-01-17","current":-146.425538,"twenty":-9.681333,"median":-5.292189,"eighty":5.026585,"marketCap":1327786780},{"date":"2025-01-24","current":-157.413425,"twenty":-9.767761,"median":-5.319085,"eighty":5.026585,"marketCap":1427424940},{"date":"2025-01-31","current":-158.289271,"twenty":-9.891758,"median":-5.346386,"eighty":5.026585,"marketCap":1435367112},{"date":"2025-02-07","current":-161.553788,"twenty":-10.055699,"median":-5.378858,"eighty":5.026585,"marketCap":1464969753},{"date":"2025-02-14","current":-156.457957,"twenty":-10.17397,"median":-5.389822,"eighty":5.026585,"marketCap":1418760752},{"date":"2025-02-21","current":-156.776446,"twenty":-10.314947,"median":-5.389822,"eighty":5.026585,"marketCap":1421648814},{"date":"2025-02-28","current":-33.014758,"twenty":-10.501006,"median":-5.389822,"eighty":5.026585,"marketCap":1426006431},{"date":"2025-03-07","current":-35.772995,"twenty":-10.665923,"median":-5.389279,"eighty":5.027845,"marketCap":1545142984},{"date":"2025-03-14","current":-37.269844,"twenty":-10.86495,"median":-5.39321,"eighty":5.027845,"marketCap":1609796358},{"date":"2025-03-21","current":-40.0449,"twenty":-11.059512,"median":-5.416297,"eighty":5.027845,"marketCap":1729659354},{"date":"2025-03-28","current":-39.288066,"twenty":-11.584839,"median":-5.468163,"eighty":5.027845,"marketCap":1696969446},{"date":"2025-04-04","current":-36.597103,"twenty":-33.014758,"median":-5.494096,"eighty":5.027845,"marketCap":1580738662},{"date":"2025-04-11","current":-31.366543,"twenty":-33.980141,"median":-5.499653,"eighty":5.026585,"marketCap":1354815076},{"date":"2025-04-17","current":-34.536834,"twenty":-34.477969,"median":-5.499653,"eighty":5.026585,"marketCap":1491749468},{"date":"2025-04-25","current":-34.57888,"twenty":-34.797521,"median":-5.494096,"eighty":5.027845,"marketCap":1493565574},{"date":"2025-05-02","current":-119.422692,"twenty":-35.873906,"median":-5.494096,"eighty":5.027845,"marketCap":2024214624},{"date":"2025-05-09","current":-115.031518,"twenty":-36.243914,"median":-5.494096,"eighty":5.027845,"marketCap":1949784238},{"date":"2025-05-16","current":-111.372207,"twenty":-37.269844,"median":-5.494096,"eighty":5.027845,"marketCap":1887758916},{"date":"2025-05-23","current":-111.716613,"twenty":-38.278955,"median":-5.494096,"eighty":5.027845,"marketCap":1893596593},{"date":"2025-05-30","current":-117.011852,"twenty":-39.002151,"median":-5.494096,"eighty":5.027845,"marketCap":1983350883},{"date":"2025-06-06","current":-127.085719,"twenty":-107.755947,"median":-5.494096,"eighty":5.027845,"marketCap":2154102945},{"date":"2025-06-13","current":-119.379641,"twenty":-112.061019,"median":-5.494096,"eighty":5.027845,"marketCap":2023484914},{"date":"2025-06-20","current":-120.240655,"twenty":-114.962637,"median":-5.482982,"eighty":5.029619,"marketCap":2038079108},{"date":"2025-06-27","current":-122.651496,"twenty":-115.806432,"median":-5.482982,"eighty":5.029619,"marketCap":2078942849},{"date":"2025-07-03","current":-120.025402,"twenty":-117.287376,"median":-5.482982,"eighty":5.029619,"marketCap":2034430559},{"date":"2025-07-11","current":-124.631829,"twenty":-119.172998,"median":-5.482982,"eighty":5.029619,"marketCap":2112509494},{"date":"2025-07-18","current":-124.158271,"twenty":-120.059843,"median":-5.482982,"eighty":5.029619,"marketCap":2104482688},{"date":"2025-07-25","current":-115.806431,"twenty":-120.257875,"median":-5.482982,"eighty":5.029619,"marketCap":1962919012},{"date":"2025-08-01","current":468.162429,"twenty":-120.257875,"median":-5.462606,"eighty":5.0428,"marketCap":2242498033},{"date":"2025-08-08","current":512.255718,"twenty":-120.257875,"median":-5.414445,"eighty":5.069484,"marketCap":2453704887},{"date":"2025-08-15","current":514.885844,"twenty":-120.257875,"median":-5.391787,"eighty":5.128954,"marketCap":2466303191},{"date":"2025-08-22","current":519.527242,"twenty":-120.257875,"median":-5.363869,"eighty":5.175541,"marketCap":2488535491},{"date":"2025-08-29","current":518.289536,"twenty":-120.257875,"median":-5.332388,"eighty":5.200913,"marketCap":2482606878},{"date":"2025-09-05","current":549.386908,"twenty":-120.275096,"median":-5.290337,"eighty":5.224226,"marketCap":2631563290},{"date":"2025-09-12","current":572.593902,"twenty":-120.257875,"median":-5.251281,"eighty":5.263063,"marketCap":2742724792},{"date":"2025-09-19","current":555.730153,"twenty":-120.257875,"median":-5.239348,"eighty":5.296439,"marketCap":2661947434},{"date":"2025-09-26","current":549.386908,"twenty":-120.257875,"median":-5.223652,"eighty":5.326174,"marketCap":2631563290},{"date":"2025-10-03","current":579.710714,"twenty":-120.257875,"median":-5.183773,"eighty":5.391712,"marketCap":2776814319},{"date":"2025-10-10","current":589.612365,"twenty":-120.257875,"median":-5.162945,"eighty":5.439927,"marketCap":2824243227},{"date":"2025-10-17","current":602.144142,"twenty":-120.257875,"median":-5.128017,"eighty":5.542736,"marketCap":2884270438},{"date":"2025-10-24","current":599.823442,"twenty":-120.257875,"median":-5.111121,"eighty":5.609628,"marketCap":2873154288},{"date":"2025-10-31","current":78.691014,"twenty":-120.275096,"median":-5.082873,"eighty":5.700057,"marketCap":2826423853},{"date":"2025-11-07","current":81.518742,"twenty":-120.275096,"median":-5.04953,"eighty":5.766345,"marketCap":2927990170},{"date":"2025-11-14","current":85.021748,"twenty":-120.275096,"median":-5.012483,"eighty":6.067631,"marketCap":3053811130},{"date":"2025-11-21","current":87.554041,"twenty":-120.275096,"median":-4.964741,"eighty":6.472834,"marketCap":3144766040},{"date":"2025-11-28","current":89.70649,"twenty":-120.275096,"median":-4.927274,"eighty":6.578179,"marketCap":3222077715},{"date":"2025-12-05","current":86.498919,"twenty":-120.275096,"median":-4.905046,"eighty":6.73327,"marketCap":3106868161},{"date":"2025-12-12","current":86.541124,"twenty":-120.275096,"median":-4.85714,"eighty":6.793745,"marketCap":3108384076},{"date":"2025-12-19","current":88.630266,"twenty":-120.275096,"median":-4.804631,"eighty":6.837639,"marketCap":3183421878},{"date":"2025-12-26","current":89.664285,"twenty":-120.275096,"median":-4.771973,"eighty":6.918598,"marketCap":3220561799},{"date":"2026-01-02","current":87.047582,"twenty":-120.275096,"median":-4.760334,"eighty":7.046377,"marketCap":3126575058},{"date":"2026-01-09","current":88.0605,"twenty":-120.275096,"median":-4.713823,"eighty":7.157574,"marketCap":3162957023},{"date":"2026-01-16","current":80.020468,"twenty":-120.275096,"median":-4.693508,"eighty":7.261943,"marketCap":2874175181},{"date":"2026-01-23","current":89.558773,"twenty":-120.275096,"median":-4.655672,"eighty":7.354607,"marketCap":3216772011},{"date":"2026-01-28","current":94.201311,"twenty":-120.275096,"median":-4.638475,"eighty":7.452148,"marketCap":3383522681}],"updateTime":1769695701727},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KNSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603864298","title":"Kiniksa Pharmaceuticals Appoints Ross Moat COO and Eben Tessari Chief Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603864298","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603864298?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:31","pubTimestamp":1768426311,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International plc has announced the appointment of Ross Moat as Chief Operating Officer, effective January 10, 2026. Moat will continue to oversee the company's commercial and functional operations. Additionally, Eben Tessari has been named Chief Strategy Officer, with ongoing responsibility for strategic, business development, technical operations, and artificial intelligence initiatives.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 14, 2026, and is solely responsib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL5jztRY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KNSA"],"gpt_icon":0},{"id":"2603140687","title":"Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2603140687","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603140687?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:01","pubTimestamp":1768312860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KNSA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 09:01 ET (14:01 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KNSA","BK4505","BK4139"],"gpt_icon":0},{"id":"2603542927","title":"Wedbush Adjusts Price Target on Kiniksa Pharmaceuticals International to $50 From $48, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542927?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:45","pubTimestamp":1768236354,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International (KNSA) has an average rating of buy and mean price target of $54.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KNSA","BK4505"],"gpt_icon":0},{"id":"2602510961","title":"Kiniksa Pharmaceuticals Showcases Pipeline Progress and Cardiovascular Focus in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510961?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:06","pubTimestamp":1768223201,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International plc has provided an update on its ongoing commercial and clinical activities. The company reported approximately $1.5 billion in net revenue since the launch of ARCALYST , with expected 2026 revenue for the therapy projected at $900 to $920 million. ARCALYST continues to expand in the recurrent pericarditis market, currently reaching about 18% penetration among patients with multiple recurrences. Kiniksa is advancing its clinical portfolio, including KPL-387, an IL-1 antagonist monoclonal antibody in development for recurrent pericarditis, which has received U.S. Orphan Drug Designation. Phase 2 data for KPL-387 is anticipated in the second half of 2026. Additionally, the company plans to initiate a first-in-human trial of KPL-1161, an Fc-modified IL-1 antagonist monoclonal antibody, by the end of 2026. As of the end of 2025, Kiniksa reported cash reserves of approximately $414 million, supporting its ongoing operations and investment in further de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5gj8hf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KNSA"],"gpt_icon":0},{"id":"2602512280","title":"Kiniksa Projects Continued Annual Cash Flow Positivity for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512280","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512280?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:30","pubTimestamp":1768221048,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International plc reported strong financial performance with ARCALYST  net product revenue reaching $677.5 million in 2025, representing approximately 62% year-over-year growth. The company expects ARCALYST net product revenue to increase further in 2026, with guidance in the range of $900 to $920 million. Kiniksa ended 2025 with $414.1 million in cash, cash equivalents, and short-term investments, reflecting a cash balance increase of $170.4 million during the year. The company anticipates its current operating plan will remain cash flow positive on an annual basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5z9yly:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","SG9999014005.SGD","BK4585","SG9999014013.SGD","BK4139","KNSA","BK4112","LU2210150020.SGD","LU0314104364.USD","BK4588","SG9999014039.USD","BK4505"],"gpt_icon":0},{"id":"2602512701","title":"Kiniksa Pharmaceuticals International Plc - Kpl-387 Phase 2 Data Expected in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512701?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:30","pubTimestamp":1768221002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA63PZMV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","KNSA"],"gpt_icon":0},{"id":"2602030116","title":"Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602030116","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602030116?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:36","pubTimestamp":1767994573,"startTime":"0","endTime":"0","summary":"Mark Ragosa, Chief Financial Officer of Kiniksa Pharmaceuticals International plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDLb1Z0Vf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KNSA","BK4505","BK4139"],"gpt_icon":0},{"id":"2593447833","title":"How Investors Are Reacting To Kiniksa (KNSA) KPL-387 Progress And A Fresh Analyst Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447833","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593447833?lang=en_us&edition=fundamental","pubTime":"2025-12-24 04:14","pubTimestamp":1766520860,"startTime":"0","endTime":"0","summary":"Earlier in December, Kiniksa Pharmaceuticals International received a Buy rating from a Wells Fargo analyst and released an update on its Phase 2 study of KPL-387 monotherapy in recurrent pericarditis, which aims to transition patients from existing regimens to this new therapy.\nThis combination of a positive analyst view and progress on KPL-387, a key pipeline asset, sharpened investor focus on Kiniksa’s long-term portfolio beyond ARCALYST.\nWe’ll now examine how the latest KPL-387 clinical...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/how-investors-are-reacting-to-kiniksa-knsa-kpl-387-progress","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/how-investors-are-reacting-to-kiniksa-knsa-kpl-387-progress","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","PRGS","KNSA"],"gpt_icon":0},{"id":"2592451319","title":"Director Barry D. Quart Reports Disposal of Kiniksa Pharmaceuticals International plc Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592451319","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592451319?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:39","pubTimestamp":1766007550,"startTime":"0","endTime":"0","summary":"Barry D. Quart, Director, reported a disposal of common shares of Kiniksa Pharmaceuticals International plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLbpBV4q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Barry D. Quart Reports Disposal of Kiniksa Pharmaceuticals International plc Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KNSA","BK4139"],"gpt_icon":0},{"id":"2591625097","title":"US High Growth Tech Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591625097?lang=en_us&edition=fundamental","pubTime":"2025-12-16 01:09","pubTimestamp":1765818555,"startTime":"0","endTime":"0","summary":"The United States market has recently experienced declines in major stock indexes, with technology shares exerting downward pressure on the Nasdaq amid concerns about an AI bubble. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience against broader market volatility.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/us-high-growth-tech-stocks-to-watch-8","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/us-high-growth-tech-stocks-to-watch-8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4097","KNSA","BK4505","GYRE","ALLT"],"gpt_icon":0},{"id":"2588703276","title":"Kiniksa COO Eben Tessari Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588703276","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588703276?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:37","pubTimestamp":1764625071,"startTime":"0","endTime":"0","summary":"Eben Tessari, Chief Operating Officer of Kiniksa Pharmaceuticals International plc, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL8dnHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kiniksa COO Eben Tessari Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KNSA","BK4505"],"gpt_icon":0},{"id":"2583829806","title":"Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583829806","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583829806?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:46","pubTimestamp":1763156774,"startTime":"0","endTime":"0","summary":"Mark Ragosa, Chief Financial Officer of Kiniksa Pharmaceuticals International plc, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL3LV7xL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KNSA"],"gpt_icon":0},{"id":"2583506655","title":"Exploring High Growth Tech Stocks in the US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2583506655","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583506655?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:08","pubTimestamp":1763118488,"startTime":"0","endTime":"0","summary":"The U.S. stock market recently experienced a significant downturn, with major indices such as the Nasdaq and S&P 500 closing sharply lower, driven by a notable decline in technology shares. In this environment of heightened volatility and economic uncertainty, identifying high-growth tech stocks requires careful consideration of their potential for innovation and resilience amidst broader market fluctuations.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/exploring-high-growth-tech-stocks-in-the-us-market-20","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/exploring-high-growth-tech-stocks-in-the-us-market-20","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","SVRA","KNSA","GYRE","BK4139"],"gpt_icon":0},{"id":"2579617017","title":"Kiniksa CFO Mark Ragosa Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2579617017","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579617017?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:47","pubTimestamp":1761857256,"startTime":"0","endTime":"0","summary":"Mark Ragosa, Chief Financial Officer of Kiniksa Pharmaceuticals International plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL1nRQvS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KNSA","BK4505"],"gpt_icon":0},{"id":"2579414749","title":"Kiniksa Pharmaceuticals International Plc : Jefferies Raises Target Price to $58 From $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2579414749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579414749?lang=en_us&edition=fundamental","pubTime":"2025-10-29 12:02","pubTimestamp":1761710527,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3W91UL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","KNSA"],"gpt_icon":0},{"id":"1168669584","title":"Stock Track | Kiniksa Pharmaceuticals Plummets 11.98% as Q3 Earnings Fall Short of Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1168669584","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168669584?lang=en_us&edition=fundamental","pubTime":"2025-10-28 21:36","pubTimestamp":1761658591,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals Ltd. (KNSA) saw its stock price plummet by 11.98% in intraday trading on Tuesday following the release of its third-quarter 2025 financial results. The biopharmaceutical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KNSA"],"gpt_icon":0},{"id":"2578950871","title":"Kiniksa Pharmaceuticals International PLC reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2578950871","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578950871?lang=en_us&edition=fundamental","pubTime":"2025-10-28 21:32","pubTimestamp":1761658349,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International PLC reports results for the quarter ended September 30 - Earnings SummaryKiniksa Pharmaceuticals International PLC KNSA.OQ reported quarterly adjusted earnings of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nL8N3W920Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KNSA"],"gpt_icon":0},{"id":"2578409954","title":"Kiniksa Pharmaceuticals Showcases Growth in Recurrent Pericarditis Market and Advances Cardiovascular Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2578409954","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578409954?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:47","pubTimestamp":1761655670,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals International plc has highlighted ongoing progress in its cardiovascular portfolio, with a particular focus on recurrent pericarditis. The company reported more than $1 billion in revenue since the launch of ARCALYST, which is approved for the treatment and reduction in risk of recurrence of recurrent pericarditis. ARCALYST revenue for 2025 is projected between $670 million and $675 million, with continued growth potential indicated by approximately 15% market penetration among patients experiencing multiple recurrences. Kiniksa also announced the advancement of its clinical pipeline, including the initiation of a Phase 2/3 trial for KPL-387 in recurrent pericarditis, with Phase 2 dose-focusing data expected in the second half of 2026. The company maintains a strong financial position, reporting cash reserves of approximately $352 million as of the third quarter of 2025. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL65FFD4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KNSA"],"gpt_icon":0},{"id":"1105135388","title":"Stock Track | Kiniksa Pharmaceuticals Plunges 6.53% Pre-Market on Q3 Earnings Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1105135388","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105135388?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:03","pubTimestamp":1761652994,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals Ltd. (KNSA) stock tumbled 6.53% in pre-market trading on Tuesday following the release of its third-quarter 2025 financial results. The biopharmaceutical company's earnings...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KNSA"],"gpt_icon":0},{"id":"2578695540","title":"Kiniksa Pharma raises ARCALYST's 2025 sales forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2578695540","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578695540?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:41","pubTimestamp":1761651689,"startTime":"0","endTime":"0","summary":"Kiniksa Pharma raises ARCALYST's 2025 sales forecastOverviewKiniksa Q3 2025 ARCALYST revenue grows 61% yr/yr to $180.9 mlnCompany raises 2025 ARCALYST revenue guidance to $670-$675 mlnKPL-387 granted ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nL1N3W90IC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KNSA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}]}}